CorMedix Inc. (NASDAQ:CRMD) Receives $14.50 Consensus PT from Brokerages
Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have received an average rating of “Buy” from the seven analysts that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year target price among […]
